Star health insurance has announced a series of analyst and institutional investor meetings scheduled for March 19, 2026 in Mumbai. The insurance company issued a formal notification to both BSE Limited and National Stock Exchange of India Limited on March 16, 2026, detailing the planned interactions with major investment firms.

Meeting Schedule and Participants

The company has organized meetings with five prominent investment firms throughout the day. The structured schedule demonstrates Star Health's commitment to maintaining regular dialogue with the investment community.

Regulatory Compliance

The meetings are being conducted in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. This regulatory framework ensures transparency in corporate communications with analysts and institutional investors.

The company has noted that the meeting schedule may be subject to changes due to exigencies on the part of analysts, investors, or the company itself.

Presentation Materials

Star Health has made presentation materials available to stakeholders through an online link. The company has also confirmed that the disclosure will be made available on its official website at www.starhealth.in , ensuring broader accessibility for interested parties.

Corporate Communication

The notification was signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, and was digitally authenticated on March 16, 2026. The formal communication was addressed to the listing departments of both major Indian stock exchanges, reflecting the company's adherence to proper disclosure protocols.

Star Health Insurance and Allied Insurance Company Limited has announced an analyst and institutional investor meeting scheduled for March 18, 2026 in Chennai. The company disclosed this information to stock exchanges in compliance with regulatory requirements under SEBI listing obligations.

Meeting Details

The scheduled meeting will involve discussions with institutional investors as part of the company's regular investor engagement activities. The meeting has been organized to provide updates and insights to the investment community.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified both BSE Limited and National Stock Exchange of India Limited about the scheduled meeting.

The company has made the presentation materials accessible through a dedicated link and also made the disclosure available on its official website at www.starhealth.in . The announcement includes a note that the meeting schedule may be subject to changes due to exigencies on the part of analysts, investors, or the company.

Documentation

The regulatory filing was signed by Jayashree Sethuraman, Company Secretary and Compliance Officer, on March 13, 2026. The document was digitally signed and submitted to the stock exchanges as part of the company's ongoing disclosure obligations to keep investors and stakeholders informed about material developments.